Long-Term Safety and Efficacy of Cannabidiol (CBD) Treatment in Patients with Dravet Syndrome (DS): 3-Year Interim Results of an Open-Label Extension (OLE) Trial (GWPCARE5)

被引：0

作者：

Halford, Jonathan J. ^{[1
]}

Scheffer, Ingrid ^{[2
,3
]}

Nabbout, Rima ^{[4
]}

Sanchez-Carpintero, Rocio ^{[5
]}

Malawky, Yael Shiloh ^{[6
]}

Wong, Matthew ^{[7
]}

Checketts, Daniel ^{[8
]}

Dunayevich, Eduardo ^{[9
]}

机构：

[1] Med Univ South Carolina, Dept Neurol, Translat Res Unit, Charleston, SC 29425 USA

[2] Univ Melbourne, Austin Hlth, Melbourne, Vic, Australia

[3] Royal Childrens Hosp, Melbourne, Vic, Australia

[4] Necker Enfants Malades Hosp, Paris, France

[5] Clin Univ Navarra, Pamplona, Spain

[6] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA

[7] Wake Forest Baptist Med Ctr, Winston Salem, NC USA

[8] GW Res Ltd, Carlsbad, CA USA

[9] Greenwich Biosci Inc, Carlsbad, CA USA

来源：

NEUROLOGY | 2020年 / 94卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

439

引用

页数：3

共 50 条

[41] SUSTAINED EFFICACY AND LONG-TERM SAFETY OF ERENUMAB IN PATIENTS WITH EPISODIC MIGRAINE: RESULTS OF A 5-YEAR, OPEN-LABEL EXTENSION STUDY
Ashina, Messoud
Goadsby, Peter J.
Reuter, Uwe
Silberstein, Stephen
Dodick, David W.
Xue, Fei
Zhang, Feng
Cheng, Sunfa
Chou, Denise E.
Lima, Gabriel Paiva da Silva
CEPHALALGIA, 2020, 40 : 60 - 61
[42] ELAMIPRETIDE IN THE MMPOWER-2 OPEN-LABEL EXTENSION TRIAL (OLE): LONG-TERM SAFETY AND TOLERABILITY
Karaa, Amel
Haas, Richard
Goldstein, Amy
Vockley, Gerard
Cohen, Bruce
MUSCLE & NERVE, 2018, 58 : S34 - S34
[43] Efficacy and Safety of Add-on Cannabidiol (CBD) for Seizures Associated With Tuberous Sclerosis Complex (TSC) in Pediatric Patients Enrolled in a Phase 3 Trial With an Open-Label Extension (OLE)
Thiele, E.
Lawson, J.
Kotulska, K.
Sahebkar, F.
Greco, T.
Saurer, T.
ANNALS OF NEUROLOGY, 2023, 94 : S57 - S57
[44] LONG-TERM EFFICACY OF LANADELUMAB: INTERIM RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
Riedl, M.
Cicardi, M.
Hao, J.
Lu, P.
Li, H.
Manning, M.
Bernstein, J.
Busse, P.
Tachdjian, R.
Gower, R.
Wedner, H.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S30 - S31
[45] Efficacy and Safety of Add-on Cannabidiol (CBD) for Seizures Associated With Tuberous Sclerosis Complex (TSC) in Pediatric Patients Enrolled in a Phase 3 Trial With an Open-Label Extension (OLE)
Thiele, E.
Lawson, J.
Kotulska, K.
Sahebkar, F.
Greco, T.
Saurer, T.
ANNALS OF NEUROLOGY, 2023, 94 : S55 - S55
[46] INTERIM LONG-TERM SAFETY/EFFICACY OF RISANKIZUMAB TREATMENT IN CROHN'S DISEASE PATIENTS FROM THE OPEN-LABEL EXTENSION STUDY
Ferrante, M.
Panes, J.
Baert, F.
Louis, E.
Kaser, A.
Gustafson, D.
Hall, D.
Boecher, W. O.
Herichova, I.
Liao, X.
Wallace, K.
Kalabic, J.
D'Haens, G.
GUT, 2019, 68 : A64 - A64
[47] Long-term safety and efficacy of Clobazam for Lennox Gastaut syndrome (LGS): 2-year results of an open label extension (OLE) study
Ng, Y. T.
Conry, J. A.
Paolicchi, J. M.
Kernitsky, L.
Mitchell, W. G.
Drummond, R.
Austin, S. A.
Weinberg, M. A.
Owen, J. R.
ANNALS OF NEUROLOGY, 2011, 70 : S140 - S140
[48] LONG-TERM SPARSENTAN TREATMENT IN YOUNG PATIENTS WITH FSGS IN THE DUET OPEN-LABEL EXTENSION (OLE)
Lieberman, Kenneth
Paredes, Ana
Srivastava, Tarak
Komers, Radko
Murphy, Edward
Prasad, Andy
Trachtman, Howard
AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S94 - S95
[49] Long-Term Safety and Efficacy of Olokizumab in Patients with Rheumatoid Arthritis - Results of an Open-Label Extension Study
Feist, Eugen
Nasonov, Evgeny
Luggen, Michael
Fatenejad, Saeed
Grishin, Sergey
Samsonov, Mikhail
Fleischmann, Roy
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 603 - 606
[50] Long-term efficacy and safety of dupilumab in adolescents with atopic dermatitis: Results from an open-label extension trial (LIBERTY AD PED-OLE)
Blauvelt, Andrew
Guttman, Emma
Hussain, Iftikhar
Chen, Zhen
Mina-Osorio, Paola
Rossi, Ana Beatris
Bansal, Ashish
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB141 - AB141

← 1 2 3 4 5 →